BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,125 | -15.5% | 6,972 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $311,451 | +12.7% | 6,836 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $276,425 | -82.3% | 6,815 | -77.7% | 0.00% | -83.3% |
| Q4 2022 | $1,558,866 | +1.6% | 30,584 | +7.3% | 0.01% | 0.0% |
| Q3 2022 | $1,535,000 | -5.0% | 28,503 | +13.3% | 0.01% | 0.0% |
| Q2 2022 | $1,616,000 | -14.5% | 25,156 | +3.3% | 0.01% | 0.0% |
| Q1 2022 | $1,889,000 | -8.8% | 24,361 | +1.0% | 0.01% | -14.3% |
| Q4 2021 | $2,071,000 | +19.0% | 24,131 | +11.5% | 0.01% | +7.7% |
| Q3 2021 | $1,741,000 | +12.3% | 21,647 | +12.4% | 0.01% | +18.2% |
| Q2 2021 | $1,550,000 | +7.9% | 19,255 | +13.1% | 0.01% | -8.3% |
| Q1 2021 | $1,436,000 | +20.9% | 17,028 | +15.0% | 0.01% | +9.1% |
| Q4 2020 | $1,188,000 | +0.2% | 14,806 | +0.4% | 0.01% | -15.4% |
| Q3 2020 | $1,186,000 | +2.6% | 14,748 | +3.5% | 0.01% | -18.8% |
| Q1 2020 | $1,156,000 | -2.6% | 14,243 | +0.3% | 0.02% | +23.1% |
| Q4 2019 | $1,187,000 | -3.9% | 14,198 | +0.5% | 0.01% | -13.3% |
| Q3 2019 | $1,235,000 | -13.3% | 14,123 | -18.8% | 0.02% | -11.8% |
| Q2 2019 | $1,424,000 | +3.8% | 17,392 | +3.1% | 0.02% | -5.6% |
| Q1 2019 | $1,372,000 | +21.5% | 16,877 | -1.6% | 0.02% | +5.9% |
| Q4 2018 | $1,129,000 | -29.7% | 17,152 | -17.7% | 0.02% | -15.0% |
| Q3 2018 | $1,607,000 | -28.3% | 20,852 | -39.7% | 0.02% | -35.5% |
| Q2 2018 | $2,241,000 | +2.0% | 34,584 | +2.4% | 0.03% | +3.3% |
| Q1 2018 | $2,197,000 | +5.8% | 33,788 | +5.1% | 0.03% | +7.1% |
| Q4 2017 | $2,077,000 | +129.5% | 32,136 | +122.6% | 0.03% | +115.4% |
| Q3 2017 | $905,000 | +167.8% | 14,434 | +158.7% | 0.01% | +116.7% |
| Q2 2017 | $338,000 | +25.7% | 5,580 | +7.4% | 0.01% | +20.0% |
| Q1 2017 | $269,000 | -17.0% | 5,195 | -28.9% | 0.01% | 0.0% |
| Q4 2016 | $324,000 | -8.2% | 7,307 | -1.6% | 0.01% | -16.7% |
| Q3 2016 | $353,000 | +6.6% | 7,428 | +1.4% | 0.01% | -14.3% |
| Q2 2016 | $331,000 | +32.9% | 7,322 | +20.6% | 0.01% | +40.0% |
| Q1 2016 | $249,000 | -56.4% | 6,070 | -59.4% | 0.01% | -61.5% |
| Q4 2015 | $571,000 | +16.3% | 14,966 | 0.0% | 0.01% | +18.2% |
| Q3 2015 | $491,000 | -60.0% | 14,966 | -14.1% | 0.01% | -56.0% |
| Q2 2015 | $1,228,000 | +19.8% | 17,414 | +16.4% | 0.02% | -3.8% |
| Q1 2015 | $1,025,000 | -72.3% | 14,955 | -70.4% | 0.03% | -73.2% |
| Q4 2014 | $3,700,000 | +88.0% | 50,487 | +84.1% | 0.10% | +131.0% |
| Q3 2014 | $1,968,000 | -4.8% | 27,430 | -4.1% | 0.04% | -6.7% |
| Q2 2014 | $2,068,000 | +29.1% | 28,604 | +31.3% | 0.04% | +25.0% |
| Q1 2014 | $1,602,000 | -55.4% | 21,780 | -57.8% | 0.04% | -58.1% |
| Q4 2013 | $3,591,000 | +545.9% | 51,641 | +509.5% | 0.09% | +473.3% |
| Q3 2013 | $556,000 | +5.3% | 8,472 | +11.4% | 0.02% | -25.0% |
| Q2 2013 | $528,000 | – | 7,607 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |